Eltrombopag 25 mg

Eltrombopag is a medication prescribed to treat low platelet counts in various conditions. This article focuses on the use of Eltrombopag25 mg in elderly patients, highlighting the specific dosage and safety considerations for this age group. Understanding these factors is essential for ensuring the well-being of older adults using this medication. What is Eltrombopag and Why 25 mg for the Elderly? Eltrombopag increases platelet production in the bone marrow and is used to treat conditions such as primary immune thrombocytopenia (ITP) and thrombocytopenia associated with hepatitis C virus (HCV) infections. In elderly patients, a lower dose of 25 mg is often preferred due to several factors: Slower Drug Processing:  Age-related changes in liver and kidney function can slow down drug metabolism. Increased Risk of Side Effects:  Higher doses may increase the risk of side effects in older adults. Other considerations:  East-Asian anc...